Gabriel Aughey,Elisa Cali,Reza Maroofian,Maha S Zaki,Alistair T Pagnamenta,Fatima Rahman,Lara Menzies,Anum Shafique,Mohnish Suri,Emmanuel Roze,Mohammed Aguennouz,Zouiri Ghizlane,Saadia Maryam Saadi,Zafar Ali,Uzma Abdulllah,Huma Arshad Cheema,Muhammad Nadeem Anjum,Godelieve Morel,Robert McFarland,Umut Altunoglu,Verena Kraus,Moneef Shoukier,David Murphy,Kristina Flemming,Hilde Yttervik,Hajar Rhouda,Gaetan Lesca,Bibi Nazia Murtaza,Mujaddad Ur Rehman,SYNAPS Study Group,Genomics England Consortium,Go Hun Seo,Christian Beetz,Hülya Kayserili,Yamna Krioulie,Wendy K Chung,Sadaf Naz,Shazia Maqbool,Joseph Gleeson,Shahid Mahmood Baig,Stephanie Efthymiou,Jenny C Taylor,Mariasavina Severino,James EC Jepson,Henry Houlden

Abstract:Retinoblastoma (RB) proteins are highly conserved transcriptional regulators that play important roles during development by regulating cell-cycle gene expression. RBL2 dysfunction has been linked to a severe neurodevelopmental disorder. However, to date, clinical features have only been described in six individuals carrying five biallelic predicted loss of function (pLOF) variants. To define the phenotypic effects of mutations in detail, we identified and clinically characterized a cohort of 28 patients from 18 families carrying LOF variants in , including fourteen new variants that substantially broaden the molecular spectrum. The clinical presentation of affected individuals is characterized by a range of neurological and developmental abnormalities. Global developmental delay and intellectual disability were uniformly observed, ranging from moderate to profound and involving lack of acquisition of key motor and speech milestones in most patients. Frequent features included postnatal microcephaly, infantile hypotonia, aggressive behaviour, stereotypic movements and non-specific dysmorphic features. Common neuroimaging features were cerebral atrophy, white matter volume loss, corpus callosum hypoplasia and cerebellar atrophy. In parallel, we used the fruit fly, , to investigate how disruption of the conserved RBL2 orthologueue Rbf impacts nervous system function and development. We found that LOF mutants recapitulate several features of patients harboring variants, including alterations in the head and brain morphology reminiscent of microcephaly, and perturbed locomotor behaviour. Surprisingly, in addition to its known role in controlling tissue growth during development, we find that continued expression is also required in fully differentiated post-mitotic neurons for normal locomotion in , and that adult-stage neuronal re-expression of is sufficient to rescue mutant locomotor defects. Taken together, this study provides a clinical and experimental basis to understand genotype-phenotype correlations in an -linked neurodevelopmental disorder and suggests that restoring expression through gene therapy approaches may ameliorate aspects of LOF patient symptoms.

Expanding the genetic and clinical spectrum of Tatton-Brown-Rahman syndrome in a series of 24 French patients

The Spectrum of DNMT3A Variants in Tatton-Brown-Rahman Syndrome Overlaps with That in Hematologic Malignancies

Aortic disease and cardiomyopathy in patients with a novel DNMT3A gene variant causing Tatton-Brown–Rahman syndrome

Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals

Bi-allelic loss-of-function variants in TMEM147 cause moderate to profound intellectual disability with facial dysmorphism and pseudo-Pelger-Huët anomaly

MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects

Clinical Case of Mild Tatton–Brown–Rahman Syndrome Caused by a Nonsense Variant in DNMT3A Gene

Biallelic pathogenic variants in TRMT1 disrupt tRNA modification and induce a syndromic neurodevelopmental disorder

Expanded phenotypic spectrum of neurodevelopmental and neurodegenerative disorder Bryant-Li-Bhoj syndrome with 38 additional individuals

Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders

Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability.

Variants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature

Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes

Clinical and molecular description of 19 patients with GATAD2B-Associated Neurodevelopmental Disorder (GAND)

De Novo Pathogenic Variant in FBRSL1, Non OMIM Gene Paralogue AUTS2, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the Literature

Pathogenic Variants in TNRC6B Cause a Genetic Disorder Characterised by Developmental Delay/intellectual Disability and a Spectrum of Neurobehavioural Phenotypes Including Autism and ADHD.

Multiple molecular diagnoses in the field of intellectual disability and congenital anomalies: 3.5% of all positive cases

Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome

Clinical and neurogenetic characterisation of autosomal recessive RBL2-associated progressive neurodevelopmental disorder

The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder

De novo variants in ATXN7L3 lead to developmental delay, hypotonia and distinctive facial features